Diannexin alleviates myocardial ischemia–reperfusion injury by orchestrating cardiomyocyte oxidative damage, macrophage polarization and fibrotic process by TLR4-NF-kB-mediated inactivation of NLRP3 inflammasome
Article in International Immunopharmacology (February 2024)